Results 131 to 140 of about 11,522 (222)
Summary This study aims to give a comprehensive overview of the one anastomosis gastric bypass (OAGB) and Roux‐en‐Y gastric bypass (RYGB) during 5 years of follow‐up in terms of weight loss, the remission of obesity‐associated diseases and complications.
Lindsy van der Laan+4 more
wiley +1 more source
Abstract Insulin has been discovered for more than a century; however, its benefits to people with diabetes are yet to be fully realized due to barriers related to access, quality of care and costs. Insulin therapy remains the cornerstone of diabetes management. The multicausality of diabetes and its subtypes calls for comprehensive phenotyping and use
Aimin Yang+4 more
wiley +1 more source
Abstract Objective γ‐Aminobutyric acid type A (GABAA) receptor positive allosteric modulators (PAMs) that lack α‐subunit selectivity, including benzodiazepines such as diazepam, exhibit antiseizure actions in animal models and in humans. ENX‐101 is a deuterated analog of the ⍺2,3,5‐selective GABAA receptor PAM L‐838,417.
Jordi Serrats+11 more
wiley +1 more source
Abstract Background Immune reconstitution inflammatory syndrome (IRIS) can occur in patients with HIV after commencing antiretroviral therapy. Tuberculosis–IRIS is the most common, and Pneumocystis jirovecii pneumonia (PJP)–IRIS accounts for only 2.7%–4% of IRIS cases.
Natasha Marcella Vaselli+3 more
wiley +1 more source
ABSTRACT Methotrexate (MTX) is a conventional systemic therapy widely used to treat chronic plaque‐type psoriasis, a chronic inflammatory skin disease that significantly impacts patients' quality of life. MTX can be administered orally or subcutaneously. Over the past decades, the use of subcutaneous versus oral MTX has been a subject of ongoing debate
Manuelle Viguier+7 more
wiley +1 more source
The Impact of Home Parenteral Nutrition on Survival and Quality of Life in Patients with Intestinal Failure and Advanced Cancer: A Comprehensive Review. [PDF]
Perlinski M, Sobocki J.
europepmc +1 more source
Abstract Background After pharmaceutical benefits scheme approval of midostaurin for fms‐like tyrosine kinase 3 (FLT3)‐mutated acute myeloid leukaemia (AML) in 2018, the Australasian Leukaemia & Lymphoma Group (ALLG) proposed a consensus approach to AML induction with 7+3 chemotherapy (7 days of infusional cytarabine with three doses of anthracycline ...
Aditya Tedjaseputra+19 more
wiley +1 more source
Recurrent Hypophosphatemia Following a Single Dose of Parenteral Iron Administration. [PDF]
Kinnera S+7 more
europepmc +1 more source
Abstract Background Optimal selection of vascular access devices is based on multiple factors and is the first strategy to reduce vascular access device‐related complications. This process is dependent on behavioural and human factors. The COM‐B (Capability, Opportunity, Motivation, Behaviour) model was used as a theoretical framework to organize the ...
Ismael Fernández‐Fernández+2 more
wiley +1 more source
Long-term Safety and Effectiveness of Rezafungin Treatment in Candidemia and Invasive Candidiasis: Results From an Early Access Program in Italy and Germany. [PDF]
Trapani F+6 more
europepmc +1 more source